Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity
Belén Palomares, Francisco Ruíz-Pino, Martín Garrido‐Rodriguez, et al.
Biochemical Pharmacology (2019) Vol. 171, pp. 113693-113693
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa
Ayat Zagzoog, Kawthar A. Mohamed, Hye Ji J. Kim, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 146
Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
Kenneth B. Walsh, Amanda E. McKinney, Andrea E. Holmes
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 99
The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer’s Disease-like Mouse Model
Juyong Kim, Pilju Choi, Young‐Tae Park, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6827-6827
Open Access | Times Cited: 29
Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn’t
Catalina Christensen, Martin Rose, Claus Cornett, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2323-2323
Open Access | Times Cited: 28
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?
Leontina Elena Filipiuc, Daniela Carmen Ababei, Teodora Alexa‐Stratulat, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1823-1823
Open Access | Times Cited: 56
Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: An overview
Carlos Villarroel-Vicente, Sergio Gutiérrez-Palomo, Jordi Ferri, et al.
European Journal of Medicinal Chemistry (2021) Vol. 221, pp. 113535-113535
Closed Access | Times Cited: 46
Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids
Rafael Franco, Rafael Rivas‐Santisteban, Irene Reyes‐Resina, et al.
Pharmacological Research (2020) Vol. 158, pp. 104801-104801
Closed Access | Times Cited: 40
Phytocannabinoids: Pharmacological effects, biomedical applications, and worldwide prospection
Ana L.G. de Brito Siqueira, Pedro V.V. Cremasco, Juliana O. Bahú, et al.
Journal of Traditional and Complementary Medicine (2023) Vol. 13, Iss. 6, pp. 575-587
Open Access | Times Cited: 16
Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs
Thomas W Murphy, Bernard Le Foll
Biomolecules (2020) Vol. 10, Iss. 6, pp. 855-855
Open Access | Times Cited: 34
Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors
Iu Raïch, Rafael Rivas‐Santisteban, Alejandro Lillo, et al.
Pharmacological Research (2021) Vol. 174, pp. 105970-105970
Open Access | Times Cited: 30
Cannabinoids and Chronic Liver Diseases
Ralph‐Sydney Mboumba Bouassa, Giada Sebastiani, Vincenzo Di Marzo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9423-9423
Open Access | Times Cited: 20
The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease
Camelia Munteanu, Betty Schwartz
Antioxidants (2023) Vol. 12, Iss. 4, pp. 903-903
Open Access | Times Cited: 13
Topical Use of Cannabis sativa L. Biochemicals
Léonid Mnekin, Lionel Ripoll
Cosmetics (2021) Vol. 8, Iss. 3, pp. 85-85
Open Access | Times Cited: 26
Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research
Diego Caprioglio, Hawraz Ibrahim M. Amin, Orazio Taglialatela‐Scafati, et al.
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1084-1084
Open Access | Times Cited: 19
Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice
Beatriz Carmona‐Hidalgo, Isabel González‐Mariscal, Adela García‐Martín, et al.
Phytomedicine (2020) Vol. 81, pp. 153426-153426
Closed Access | Times Cited: 25
Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment
Klaudia Berk, Wiktor Bzdęga, Karolina Konstantynowicz-Nowicka, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 393-393
Open Access | Times Cited: 22
Targeting the endocannabinoid system: Structural determinants and molecular mechanism of allosteric modulation
Jiayi Yuan, Bo Ram Yang, Guanyu Hou, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103615-103615
Open Access | Times Cited: 8
Investigation of Cannabinoid Acid/Cyclodextrin Inclusion Complex for Improving Physicochemical and Biological Performance
Chulhun Park, Jieyu Zuo, Myung-Chul Gil, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2533-2533
Open Access | Times Cited: 8
Δ9‐Tetrahydrocannabinolic acid alleviates collagen‐induced arthritis: Role of PPARγ and CB1receptors
Belén Palomares, Martín Garrido‐Rodriguez, Claudia Gonzalo‐Consuegra, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 17, pp. 4034-4054
Open Access | Times Cited: 19
STAP-2 facilitates insulin signaling through binding to CAP/c-Cbl and regulates adipocyte differentiation
Yuichi Sekine, Kazuna Kikkawa, Sachie Honda, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Pharmacokinetic Investigation of Commercially Available Edible Marijuana Products in Humans: Potential Influence of Body Composition and Influence on Glucose Control
Taylor Russell Ewell, Kieran Shay Struebin Abbotts, Natasha Williams, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 8, pp. 817-817
Open Access | Times Cited: 15
Hemp Seed Oil Inhibits the Adipogenicity of the Differentiation-Induced Human Mesenchymal Stem Cells through Suppressing the Cannabinoid Type 1 (CB1)
Albatul S. Almousa, Pandurangan Subash‐Babu, Ibrahim O. Alanazi, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1568-1568
Open Access | Times Cited: 2
Lower Rates of Hepatocellular Carcinoma Observed Among Cannabis Users: A Population-Based Study
Ahmed ElTelbany, George Khoudari, Yasser Al‐Khadra, et al.
Cureus (2022)
Open Access | Times Cited: 10
Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions
Nicole Paland, Haya Hamza, Antonia Pechkovsky, et al.
Rambam Maimonides Medical Journal (2023) Vol. 14, Iss. 4, pp. e0022-e0022
Open Access | Times Cited: 5
Comparative metabolism of THCA and THCV using UHPLC-Q-Exactive Orbitrap-MS
Qianru Rao, Ting Zhang, Qianlun Pu, et al.
Xenobiotica (2023) Vol. 53, Iss. 1, pp. 46-59
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top